These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 449003)

  • 21. Identifying the causative proteins of similar side effect pairs to explore the common molecular basis of these side effects.
    Wang Y; Chen X; Liu L; Chen Y; Ma H; Yang R; Liu X
    Mol Biosyst; 2015 Jul; 11(7):2060-7. PubMed ID: 25992869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are non-serious adverse reactions to psychiatric drugs really non-serious?
    Pozzi M; Bertella S; Cattaneo D; Molteni M; Perrone V; Carnovale C; Antoniazzi S; Clementi E; Radice S
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):394-400. PubMed ID: 23952186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional study.
    Ahern F; Sahm LJ; Lynch D; McCarthy S
    Emerg Med J; 2014 Jan; 31(1):24-9. PubMed ID: 23389832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse drug reactions - allergy? side-effect? intolerance?
    Smith W
    Aust Fam Physician; 2013; 42(1-2):12-6. PubMed ID: 23529453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse drug reactions: part II.
    Wooten JM
    South Med J; 2010 Nov; 103(11):1138-45; quiz 1146-7. PubMed ID: 20890249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.
    Arimone Y; Miremont-Salamé G; Haramburu F; Molimard M; Moore N; Fourrier-Réglat A; Bégaud B
    Br J Clin Pharmacol; 2007 Oct; 64(4):482-8. PubMed ID: 17711539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
    Yang W; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse drug reactions: Part I.
    Wooten JM
    South Med J; 2010 Oct; 103(10):1025-8; quiz 1029. PubMed ID: 20818299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased use in propofol and reported patterns of adverse events among anesthetics in Korea.
    Park HJ; Shin JY; Kim MH; Park BJ
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):478-83. PubMed ID: 25666110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-point checklist of dermoscopy. A new screening method for early detection of melanoma.
    Soyer HP; Argenziano G; Zalaudek I; Corona R; Sera F; Talamini R; Barbato F; Baroni A; Cicale L; Di Stefani A; Farro P; Rossiello L; Ruocco E; Chimenti S
    Dermatology; 2004; 208(1):27-31. PubMed ID: 14730233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Filtering big data from social media--Building an early warning system for adverse drug reactions.
    Yang M; Kiang M; Shang W
    J Biomed Inform; 2015 Apr; 54():230-40. PubMed ID: 25688695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The design of an algorithm for pharmacists to evaluate ADRs in the elderly.
    Trewin VF
    J Clin Pharm Ther; 1991 Feb; 16(1):45-53. PubMed ID: 2026668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
    Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F;
    Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug reactions in a south Indian hospital--their severity and cost involved.
    Ramesh M; Pandit J; Parthasarathi G
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):687-92. PubMed ID: 14762985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reporting of fatal adverse drug reactions.
    Liu BA; Knowles SR; Mittmann N; Einarson T; Shear NH
    Can J Clin Pharmacol; 2001; 8(2):84-8. PubMed ID: 11493936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A scale for assessing the severity of diseases and adverse drug reactions. Application to drug benefit and risk.
    Tallarida RJ; Murray RB; Eiben C
    Clin Pharmacol Ther; 1979 Apr; 25(4):381-90. PubMed ID: 428184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing methods for causality assessment of suspected adverse drug reactions.
    Hutchinson TA; Lane DA
    J Clin Epidemiol; 1989; 42(1):5-16. PubMed ID: 2913186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse drug reactions--a computer-assisted application of correspondence analysis for automatic causality assessment.
    Bastin C; Wertheimer P; Venulet J
    Methods Inf Med; 1984 Oct; 23(4):183-8. PubMed ID: 6513792
    [No Abstract]   [Full Text] [Related]  

  • 40. Adverse drug reactions without drugs.
    Reidenberg MM
    Lancet; 1967 Oct; 2(7521):892. PubMed ID: 12389559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.